Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > NDA approval

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on May 24, 2024 3:50am

130 Views

Post# 36055296

RE:RE:RE:RE:NDA approval

Always pile low... When approval comes and the market recognizes that Labs has full market access in the US, the stock price won't be at 0.25 cents... as previously stated, Pidduck said in the CC for Q3 2022 that Labs has filed an NDA and an ANDA with its pharma partner So it's just a matter of time, but eventually the good news will come

<< Previous

Bullboard Posts

Next >>

Grand Portage Resources pioneers new gold exploration in Alaska